Image

Circadian Variation of Anti-Factor Xa in Hospitalized Trauma Patients

Circadian Variation of Anti-Factor Xa in Hospitalized Trauma Patients

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to determine whether a circadian rhythm exists in anti-FXa levels and AT3 activity in hospitalized trauma patients receiving low-molecular-weight heparin (LMWH) chemoprophylaxis

Eligibility

Inclusion Criteria:

  • Inpatient admission for acute traumatic injury ≥72 hours
  • Prescribed LMWH subcutaneous for VTE chemoprophylaxis

Exclusion Criteria:

  • Pregnancy
  • Brain hemorrhage or non-survivable injury
  • Chronic Kidney disease ≥ 3b estimated Glomerular Filtration Rate (eGFR) less than 30 interferes with coagulation
  • Chronic liver failure

    •-Acute stimulant use of cocaine and methamphetamine

  • Active VTE or ongoing anticoagulation at admission
  • History of coagulopathy or inherited bleeding disorders
  • Chronic alcohol as defined as a documented diagnosis of alcohol use disorder or alcohol consumption exceeding established risk thresholds (men \>14 drinks/week; women \>7 drinks/week) within the prior 3-6 months
  • Unmanaged psychiatric conditions as defined as diagnosed psychiatric disorder with evidence of inadequate or no active treatment or documented poor symptom control
  • Neurologic injury involving hypothalamic or circadian regulatory centers

Study details
    Circadian Variation in Anti-Factor Xa (Anti-FXa) Activity

NCT07856641

The University of Texas Health Science Center, Houston

3 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.